Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueInventory Average

RedHill Biopharma (RDHL) Debt Ratio (2020 - 2022)

Historic Debt Ratio for RedHill Biopharma (RDHL) over the last 3 years, with Q4 2022 value amounting to 1.45.

  • RedHill Biopharma's Debt Ratio rose 21428.25% to 1.45 in Q4 2022 from the same period last year, while for Dec 2022 it was 1.45, marking a year-over-year increase of 21428.25%. This contributed to the annual value of 1.45 for FY2022, which is 21428.25% up from last year.
  • RedHill Biopharma's Debt Ratio amounted to 1.45 in Q4 2022, which was up 21428.25% from 0.72 recorded in Q3 2022.
  • RedHill Biopharma's Debt Ratio's 5-year high stood at 1.45 during Q4 2022, with a 5-year trough of 0.37 in Q1 2021.
  • In the last 3 years, RedHill Biopharma's Debt Ratio had a median value of 0.48 in 2020 and averaged 0.57.
  • In the last 5 years, RedHill Biopharma's Debt Ratio plummeted by 3118.33% in 2021 and then soared by 21428.25% in 2022.
  • Over the past 3 years, RedHill Biopharma's Debt Ratio (Quarter) stood at 0.45 in 2020, then grew by 2.21% to 0.46 in 2021, then skyrocketed by 214.28% to 1.45 in 2022.
  • Its Debt Ratio stands at 1.45 for Q4 2022, versus 0.72 for Q3 2022 and 0.51 for Q2 2022.